XTL Biopharmaceutica (Israel) Today
| XTLB Stock | ILS 4.50 0.10 2.27% |
PerformanceVery Weak
| Odds Of DistressQuite High
|
XTL Biopharmaceutica is trading at 4.50 as of the 23rd of March 2025, a 2.27 percent increase since the beginning of the trading day. The stock's open price was 4.4. XTL Biopharmaceutica has more than 65 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 23rd of December 2024 and ending today, the 23rd of March 2025. Click here to learn more.
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. XTL Biopharmaceuticals Ltd. was founded in 1993 and is headquartered in Ramat Gan, Israel. The company has 514.21 M outstanding shares. More on XTL Biopharmaceuticals
Moving together with XTL Stock
Moving against XTL Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
XTL Biopharmaceuticals Risk Profiles
Although XTL Biopharmaceutica's alpha and beta are two of the key measurements used to evaluate XTL Biopharmaceutica's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.19 | |||
| Standard Deviation | 4.09 | |||
| Variance | 16.75 | |||
| Risk Adjusted Performance | (0.09) |
XTL Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in XTL Biopharmaceutica without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
Other Information on Investing in XTL Stock
XTL Biopharmaceutica financial ratios help investors to determine whether XTL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in XTL with respect to the benefits of owning XTL Biopharmaceutica security.